SORBS1 and breast carcinoma: Consistent with those results, analyses of two independent Oncomine data-sets, Richardson Breast 2 and Curtis Breast, revealed that SORBS1 mRNA levels were lower in breast carcinoma patient samples (Richardson Breast 2,N = 40; Curtis Breast, N = 14) compared with those in normal breast samples (Richardson Breast 2, N = 7; Curtis Breast, N = 144) (Figure 1B, Supplementary Table S1).